Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Inv. presentation
Quarterly results

Harpoon Therapeutics, Inc. (HARP) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/09/2023 8-K Quarterly results
Docs: "Harpoon Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update"
03/27/2023 8-K Quarterly results
11/14/2022 8-K Quarterly results
08/10/2022 8-K Quarterly results
05/12/2022 8-K Quarterly results
03/10/2022 8-K Quarterly results
11/10/2021 8-K Quarterly results
Docs: "Harpoon Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporate Update SOUTH SAN FRANCISCO, Calif., November 10, 2021"
08/05/2021 8-K Quarterly results
Docs: "Harpoon Therapeutics Reports Second Quarter 2021 Financial Results and Provides Corporate Update Presented updated interim Phase 1/2a clinical trial data for PSMA-targeting TriTAC® HPN424 in prostate cancer at ASCO Annual Meeting Provided clinical trial updates for three additional TriTAC programs and ProTriTAC platform"
05/06/2021 8-K Quarterly results
03/10/2021 8-K Quarterly results
11/04/2020 8-K Quarterly results
Docs: "Harpoon Therapeutics Reports Third Quarter 2020 Financial Results and Provides Corporate Update"
08/05/2020 8-K Quarterly results
05/06/2020 8-K Quarterly results
Docs: "Harpoon Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Update"
03/12/2020 8-K Quarterly results
11/06/2019 8-K Quarterly results
Docs: "Harpoon Therapeutics Reports Third Quarter 2019 Financial Results and Provides Corporate Update"
08/05/2019 8-K Quarterly results
05/09/2019 8-K Quarterly results
Docs: "Harpoon Therapeutics Reports First Quarter 2019 Financial Results and Provides Corporate Update"
03/14/2019 8-K Quarterly results
Docs: "Harpoon Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy